Literature DB >> 8405746

Partitioning the symptoms of hypoglycaemia using multi-sample confirmatory factor analysis.

I J Deary1, D A Hepburn, K M MacLeod, B M Frier.   

Abstract

The allocation of hypoglycaemic symptoms to autonomic or neuroglycopenic groups tends to occur on an a priori basis. In view of the practical need for clear symptom markers of hypoglycaemia more scientific approaches must be pursued. Substantial evidence is presented from two large scale studies we performed which support a three factor model of hypoglycaemic symptomatology, based on the statistical associations discovered among symptoms reported by diabetic patients. Study 1 involved 295 insulin-treated out-patients and found that 11 key hypoglycaemic symptoms segregated into three clear factors: autonomic (sweating, palpitation, shaking and hunger) neuroglycopenic (confusion, drowsiness, odd behaviour, speech difficulty and incoordination), and malaise (nausea and headache). The three factors were validated on a separate group of 303 insulin-treated diabetic out-patients. Confirmatory factor analyses showed that the three factor model was the optimal model for explaining symptom covariance in each group. A multi-sample confirmatory factor analysis tested the rigorous assumptions that the relative loadings of symptoms on factors across groups were equal, and that the residual variance for each symptom was identical across groups. These assumptions were successful, indicating that the three factor model was replicated in detail across these two large samples. It is suggested that the results indicate valid groupings of symptoms that may be used in future research and in clinical practice.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8405746     DOI: 10.1007/bf00401150

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  22 in total

1.  Classification of symptoms of hypoglycaemia in insulin-treated diabetic patients using factor analysis: relationship to hypoglycaemia unawareness.

Authors:  D A Hepburn; I J Deary; B M Frier
Journal:  Diabet Med       Date:  1992 Jan-Feb       Impact factor: 4.359

2.  Cognitive function during hypoglycaemia in type I diabetes mellitus.

Authors:  S Pramming; B Thorsteinsson; A Theilgaard; E M Pinner; C Binder
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-08

3.  Hypoglycaemic reactions in 172 Type 1 (insulin-dependent) diabetic patients.

Authors:  C Goldgewicht; G Slama; L Papoz; G Tchobroutsky
Journal:  Diabetologia       Date:  1983-02       Impact factor: 10.122

4.  Reliability of symptom-blood glucose relationships among insulin-dependent adult diabetics.

Authors:  D J Cox; L Gonder-Frederick; S Pohl; J W Pennebaker
Journal:  Psychosom Med       Date:  1983-08       Impact factor: 4.312

5.  Unawareness of hypoglycaemia in insulin-treated diabetic patients: prevalence and relationship to autonomic neuropathy.

Authors:  D A Hepburn; A W Patrick; D W Eadington; D J Ewing; B M Frier
Journal:  Diabet Med       Date:  1990 Sep-Oct       Impact factor: 4.359

6.  Hypoglycemic symptoms and frequency of severe hypoglycemia in patients treated with human and animal insulin preparations.

Authors:  I Mühlhauser; L Heinemann; E Fritsche; K von Lennep; M Berger
Journal:  Diabetes Care       Date:  1991-08       Impact factor: 19.112

7.  Is it a hypo? Knowledge of the symptoms of hypoglycaemia in elderly diabetic patients.

Authors:  W J Mutch; I Dingwall-Fordyce
Journal:  Diabet Med       Date:  1985-01       Impact factor: 4.359

8.  Symptomatic hypoglycaemia in childhood diabetes: a population-based questionnaire study.

Authors:  J Aman; I Karlsson; L Wranne
Journal:  Diabet Med       Date:  1989-04       Impact factor: 4.359

9.  Symptomatic awareness of hypoglycaemia: does it change on transfer from animal to human insulin?

Authors:  D A Hepburn; D W Eadington; A W Patrick; N R Colledge; B M Frier
Journal:  Diabet Med       Date:  1989 Sep-Oct       Impact factor: 4.359

10.  Accuracy of perceiving blood glucose in IDDM.

Authors:  D J Cox; W L Clarke; L Gonder-Frederick; S Pohl; C Hoover; A Snyder; L Zimbelman; W R Carter; S Bobbitt; J Pennebaker
Journal:  Diabetes Care       Date:  1985 Nov-Dec       Impact factor: 19.112

View more
  55 in total

1.  Experimental non-severe hypoglycaemia substantially impairs cognitive function in type 2 diabetes: a randomised crossover trial.

Authors:  Malin Nilsson; Nicole Jensen; Michael Gejl; Marianne L Bergmann; Heidi Storgaard; Mette Zander; Kamilla Miskowiak; Jørgen Rungby
Journal:  Diabetologia       Date:  2019-07-31       Impact factor: 10.122

2.  Brain white matter lesions detected by magnetic resonance [correction of resosnance] imaging are associated with balance and gait speed.

Authors:  J M Starr; S A Leaper; A D Murray; H A Lemmon; R T Staff; I J Deary; L J Whalley
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-01       Impact factor: 10.154

Review 3.  Metabolic neuroimaging of the brain in diabetes mellitus and hypoglycaemia.

Authors:  Yee-Seun Cheah; Stephanie A Amiel
Journal:  Nat Rev Endocrinol       Date:  2012-06-26       Impact factor: 43.330

4.  Critical role for GLP-1 in symptomatic post-bariatric hypoglycaemia.

Authors:  Colleen M Craig; Li-Fen Liu; Carolyn F Deacon; Jens J Holst; Tracey L McLaughlin
Journal:  Diabetologia       Date:  2016-12-14       Impact factor: 10.122

5.  Acute stress modulates symptom awareness and hormonal counterregulation during insulin-induced hypoglycemia in healthy individuals.

Authors:  J Pohl; G Frenzel; W Kerner; G Fehm-Wolfsdorf
Journal:  Int J Behav Med       Date:  1998

6.  Clinical heterogeneity and novel mutations in the glycerol kinase gene in three families with isolated glycerol kinase deficiency.

Authors:  D R Sjarif; R J Sinke; M Duran; F A Beemer; W J Kleijer; J K Ploos van Amstel; B T Poll-The
Journal:  J Med Genet       Date:  1998-08       Impact factor: 6.318

7.  Counterregulatory responses to hypoglycemia differ between glimepiride and glyburide in non diabetic individuals.

Authors:  Nino G Joy; Donna B Tate; Stephen N Davis
Journal:  Metabolism       Date:  2015-02-26       Impact factor: 8.694

8.  Development and Psychometric Evaluation of the Hypoglycemia Perspectives Questionnaire in Patients with Type 2 Diabetes Mellitus.

Authors:  Ariane K Kawata; Hilary Wilson; Siew Hwa Ong; Karoly Kulich; Karin Coyne
Journal:  Patient       Date:  2016-10       Impact factor: 3.883

9.  Effects of differing antecedent increases of plasma cortisol on counterregulatory responses during subsequent exercise in type 1 diabetes.

Authors:  Shichun Bao; Vanessa J Briscoe; Donna B Tate; Stephen N Davis
Journal:  Diabetes       Date:  2009-06-09       Impact factor: 9.461

10.  Effects of antecedent GABAA activation with alprazolam on counterregulatory responses to hypoglycemia in healthy humans.

Authors:  Maka S Hedrington; Stephnie Farmerie; Andrew C Ertl; Zhihui Wang; Donna B Tate; Stephen N Davis
Journal:  Diabetes       Date:  2010-01-19       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.